文献速递眼底病与葡萄膜炎

局部S100A8水平与实验性自身免疫性葡萄膜炎复发相关并促进致病性T细胞活性

Local S100A8 Levels Correlate With Recurrence of Experimental Autoimmune Uveitis and Promote Pathogenic T Cell Activity.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2018-01-01

研究在Lewis大鼠中用IRBP R16肽特异性T细胞诱导复发性实验性自身免疫性葡萄膜炎(tEAU),发现眼内S100A8而非HMGB1与眼内炎症发作相关。给予S100抑制剂帕喹莫德可显著防止tEAU大鼠复发,并减少R16特异性Th1和Th17细胞、增加Tregs。作者认为完全阻断S100A8/A9可能是复发性自身免疫性葡萄膜炎的新治疗靶点。

要点

  • 眼内S100A8水平与tEAU大鼠的眼内炎症发作相关,而HMGB1无此相关。
  • 帕喹莫德治疗显著防止tEAU大鼠复发,并减少R16特异性Th1和Th17细胞、增加Tregs。
  • 作者认为完全阻断S100A8/A9可能是复发性自身免疫性葡萄膜炎的新治疗靶点。

核心结论

  • 数据表明损伤相关分子模式(DAMP)的局部表达与自身免疫反应之间存在联系,并提示完全阻断S100A8/A9可能是复发性自身免疫性葡萄膜炎的新治疗靶点。

研究设计与样本

  • 在Lewis大鼠中通过IRBP R16肽特异性T细胞诱导复发性实验性自身免疫性葡萄膜炎(tEAU)。
  • 动态收集房水和血清样本,采用定量蛋白质组学、Western blot分析和ELISA检测DAMP。
  • 对tEAU大鼠给予S100抑制剂帕喹莫德后评估疾病,并比较治疗组与未治疗组的T效应细胞和T调节细胞(Tregs)功能。
  • 通过流式细胞术检测抗原呈递细胞上共刺激分子的表达。

主要发现

  • 眼内S100A8而非高迁移率族蛋白B1(HMGB1)与眼内炎症发作相关。
  • 给予帕喹莫德显著保护tEAU大鼠免于复发。
  • 治疗组tEAU大鼠R16特异性Th1和Th17细胞较少,但Tregs数量增加。
  • 将治疗组tEAU大鼠的R16特异性T细胞转入初始受体后,可阻止未治疗组tEAU大鼠的R16特异性T细胞诱导tEAU。
  • 与未治疗组tEAU大鼠的APC相比,治疗组APC表达更高水平的负性共刺激分子CD200R和更低水平的CD80、CD86及MHC II类分子;体外与重组S100A8孵育的APC呈现相反的表达模式。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the role of damage-associated molecular patterns (DAMPs) in recurrent experimental autoimmune uveitis (EAU). METHODS: Recurrent EAU was induced in Lewis rats by interphotoreceptor retinoid-binding protein (IRBP) R16-peptide specific T cells (tEAU). Aqueous humor and serum samples were kinetically collected and DAMPs examined by quantitative proteomics, Western blot analysis, and ELISA. tEAU rats were treated with S100 inhibitor paquinimod followed by disease evaluation. The functions of T effector cells and T regulatory cells (Tregs) were compared between treated and nontreated groups. The expression of costimulatory molecules on antigen-presenting cells was examined by flow cytometry. RESULTS: S100A8, but not high mobility group box 1 (HMGB1), in the eye was found to be correlated with intraocular inflammatory episodes. Administration of paquinimod significantly protected tEAU rats from recurrence. Treated tEAU rats had fewer R16-specific Th1 and Th17 cells, but increased numbers of Tregs. R16-specific T cells from treated tEAU rats into naïve recipients prevented induction of tEAU by R16-specific T cells from nontreated tEAU rats. Moreover, APCs from treated tEAU rats expressed higher levels of a negative costimulatory molecule, CD200R, and lower levels of CD80, CD86, and MHC class II molecules compared to APCs from nontreated tEAU rats. An opposite pattern of expression of these molecules was observed on APCs incubated in vitro with recombinant S100A8. CONCLUSIONS: Our data demonstrate a link between local expression of DAMPs and autoimmune responses, and suggest that complete S100A8/A9 blockade may be a new therapeutic target in recurrent autoimmune uveitis.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Yun J, Xiao T, Zhou L, et al. Local S100A8 Levels Correlate With Recurrence of Experimental Autoimmune Uveitis and Promote Pathogenic T Cell Activity. Invest Ophthalmol Vis Sci. 2018. PMID: 29625456. doi:10.1167/iovs.17-23127

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。